This website uses cookies to enhance the user experience.
||
A

AXCELLERA HOLDING AS989 210 785

Purchase and sale
Limited company
Ruglandveien 11 1358 JAR, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

AXCELLERA HOLDING AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
YK

Yngve Kristiansen1966

Chairman of the board
YK

Yngve Kristiansen1966

Years since formation
19 years
since Jan 14, 2006
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
185,850
NOK
Annual total result 2024
815,196
NOK
Total equity 2024
1,872,732
NOK
Last update: Aug 9, 2025

Management

Management / administration

NameRoleShares
YK

Yngve Kristiansen

1966

Managing Director/CEO
100 %
directly

Board

NameRoleShares
YK

Yngve Kristiansen

1966

Chairman
100 %
directly
AW

Anja Wikborg

1971

Alternate Member-

Others

NameRoleShares
S
SPAREBANK 1 SØR-NORGE FORRETNINGSPARTNER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
YK

Yngve Kristiansen

1966

Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
YK

Yngve Kristiansen

1966

Ordinary shares
100
100 %

Shares owned by the AXCELLERA HOLDING AS

NameShare classTotal number of sharesShare
P
PROVIDA MEDICAL AS
Ordinary shares
30,000
100 %
B
BLUE GLACIER AS
Ordinary shares
30,000
100 %
I
INNEOX AS
Ordinary shares
500,000
50 %
E
EDGE INNOVATION HOLDING AS
Ordinary shares
25,000
50 %
P
PROVIDA INNOVATION AS
Ordinary shares
15,000
50 %
E
EDGE INNOVATION OSLO AS
Ordinary shares
3,000
10 %
R
RÅTASS GRUPPEN AS
Ordinary shares
3,750
9.19 %
Last update: Jun 2, 2025

Group structure

  • AXCELLERA HOLDING AS
    Total operating income 2024: NOK 185,850
    Operating profit 2024: NOK -222,705
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
185,850
1,094,400
1,077,350
2,390,290
Annual Total Result
815,196
546,166
704,258
1,974,667
Total assets
3,350,622
2,300,826
2,724,970
3,563,330
Total liabilities
1,477,890
218,290
641,747
1,199,486
Total equity
1,872,732
2,082,536
2,083,223
2,363,844

P&L

Year2024202320222021
Total operating income
185,850
1,094,400
1,077,350
2,390,290
Total operating costs
408,555
543,314
394,358
307,158
Operating result
-222,705
551,086
682,992
2,083,132
Financial income/costs
1,037,901
-3,766
21,781
93,339
Profit before tax
815,196
547,320
704,773
2,176,471
Total tax & extraordinary income/cost
0
1,154
515
201,804
Annual Total Result
815,196
546,166
704,258
1,974,667

Balance overview

Year2024202320222021
Total fixed assets
115,182
115,182
115,182
100,182
Total current assets
3,235,440
2,185,644
2,609,788
3,463,148
Total assets
3,350,622
2,300,826
2,724,970
3,563,330
Short term debt
1,477,890
218,290
641,747
1,199,486
Long term debt
0
0
0
0
Total liabilities
1,477,890
218,290
641,747
1,199,486
Contributed capital
100,000
100,000
100,000
100,000
Retained earnings
1,772,732
1,982,536
1,983,223
2,263,844
Total equity
1,872,732
2,082,536
2,083,223
2,363,844
Total equity and liabilities
3,350,622
2,300,826
2,724,970
3,563,330

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods